Endogenous Hydrogen Sulfide is Impaired in Patients with Chronic Obstructive Pulmonary Disease

Y. Chen,Y. Sun,K. Wang,W. He,J. Chang,C. Liao,F. Lin,Y. Qi
DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2013.009.004
IF: 24.7
2014-01-01
American Journal of Respiratory and Critical Care Medicine
Abstract:Objective To investigate the expression of endogenous H2S in lung tissue from chronic obstructive pulmonary disease (COPD) patients.Methods Peripheral lung tissue samples were collected from 24 patients-11 nonsmokers,7 smokers who had normal lung function and 6 COPD patients.Histological changes of lungs were observed under light microscope.The content of glutathione (GSH)and the activity of superoxide dismutase (SOD) were detected to reflect oxidative stress.The protein and mRNA levels of endogenous H2 S synthetase were analyzed.The level of H2 S in lung tissue was analyzed by the sensitive sulphur electrode assay.Results FEV1/FVC and proportion of predicted FEV1 were significantly lower in patients with COPD than in smokers and nonsmokers.GSH and SOD were decreased in lung tissue of COPD and smokers.When compared with nonsmokers,the protein level of cystathionine-γ-lyase (CSE,the major enzyme producing H2S in the cardiovascular and respiratory system) was decreased in lung tissue from smokers and COPD patients by 35% and 39% respectively.However CSE mRNA was increased in COPD patients.There was no significant difference in H2S levels in lung tissue in each group.Immunohistochemistry showed that CSE was mainly expressed in bronchial and alveolar epithelial cells in nonsmokers' lung tissue.In smokers and COPD patients,CGL expression was decreased.Conclusions Endogenous H2S is impaired in patients with COPD.
What problem does this paper attempt to address?